Tag: bioatla, inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to bioatla, inc.

Pyxis Oncology Announces Worldwide Licensing Agreement with Pfizer to Develop and ...

Added to Collection on: 2021-03-18 12:00:00

Tags for this article:

Companies
Life Sciences
Pharmaceutical companies
Tonix Pharmaceuticals
NASDAQ
Pfizer
Novartis
Champions Oncology Inc.
Omnicell Inc.
savara inc
Pfizer Inc.
Merck
Sierra Oncology Inc
Immunocore Holdings plc
Vincerx Pharma Inc.
Celcuity
Harvard Bioscience Inc.
Galecto Inc.
WuXi Biologics
Sol-Gel Technologies Ltd.
bioatla, inc.
Myriad Genetics Inc.

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates ...

Added to Collection on: 2021-03-18 12:11:15

Tags for this article:

Nasdaq, Inc.
Companies
Life Sciences
Economy of New York City
NASDAQ
Gilead Sciences
N-Shares
AstraZeneca
Amicus Therapeutics
Adverum Biotechnologies
Organogenesis Holdings Inc
Omnicell Inc.
Sierra Oncology Inc
ideaya biosciences, inc
Foghorn Therapeutics Inc.
Translate Bio
Galapagos NV
S&P 600 SMALL CAP INDEX
NuVasive Inc.
PLx Pharma Inc
Urovant Sciences Ltd.
Silverback Therapeutics Inc.
Abu Dhabi SE Industrial Index
Anixa Biosciences Inc.
Harvard Bioscience Inc.
STRATA Skin Sciences Inc
NGM Biopharmaceuticals Inc.
Oncternal Therapeutics Inc.
Galecto Inc.
AngioDynamics Inc.
bioatla, inc.

Click the tags to see associated articles and topics

View Article Details
BioAtla Announces First Quarter 2021 Financial Results And Provides Business Update

Added to Collection on: 2021-05-12 22:18:45

Tags for this article:

Clinical medicine
Cancer treatments
Medicine
Antineoplastic drugs
Orphan drugs
Cancer immunotherapy
Breakthrough therapy
Immune system
AXL receptor tyrosine kinase
Ipilimumab
Pembrolizumab
Checkpoint inhibitor
United States
SAN DIEGO
bioatla, inc.

Click the tags to see associated articles and topics

View Article Details
Lawrence Steinman Sells 450 Shares of BioAtla, Inc. (NASDAQ:BCAB) Stock

Added to Collection on: 2021-07-20 14:48:45

Tags for this article:

Finance
Money
Economy
Financial markets
Stock market
Wagering
Financial regulation
Short
Stock
Sports betting
Hedge fund
Securities research
bioatla, inc.

Click the tags to see associated articles and topics

View Article Details
BioAtla Announces Second Quarter 2021 Financial Results And Provides Clinical Update

Added to Collection on: 2021-08-13 22:09:08

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Immunology
Immune system
Biotechnology
Antineoplastic drugs
Cancer immunotherapy
Antibody-drug conjugate
AXL receptor tyrosine kinase
Monoclonal antibody therapy
Ipilimumab
United States
bioatla, inc.

Click the tags to see associated articles and topics

View Article Details
Q3 2021 EPS Estimates for BioAtla, Inc. Decreased by Analyst (NASDAQ:BCAB) | MarketBeat

Added to Collection on: 2021-08-18 12:33:45

Tags for this article:

Finance
Money
Financial markets
Corporate finance
Financial ratios
Stock market
Fundamental analysis
Stock
Earnings per share
Securities research
NASDAQ
Short
bioatla, inc.

Click the tags to see associated articles and topics

View Article Details
BIOATLA APPOINTS EDWARD L. WILLIAMS TO BOARD OF DIRECTORS - Yahoo Finance

Added to Collection on: 2021-12-21 14:15:36

Tags for this article:

Life Sciences
Biotechnology
Health care
Clinical medicine
Immunology
Antibody-drug conjugate
Jay Short
Biopharmaceutical
Monoclonal antibody therapy
Seagen
Edward L. Eddie Williams
SAN DIEGO
bioatla, inc.

Click the tags to see associated articles and topics

View Article Details
BioAtla, Inc. Forecasted to Earn Q1 2022 Earnings of ($0.68) Per Share (NASDAQ:BCAB ...

Added to Collection on: 2022-03-05 00:21:38

Tags for this article:

Finance
Money
Economy
Corporate finance
Fundamental analysis
Stock market
Financial ratios
Valuation
Stock
Securities research
Earnings per share
BlackRock
bioatla, inc.

Click the tags to see associated articles and topics

View Article Details
BioAtla (NASDAQ:BCAB) Trading Down 3.8% - MarketBeat

Added to Collection on: 2024-07-09 06:54:52

Tags for this article:

Institutional investors
Hedge funds
Equity securities
NASDAQ
Class B share
Wainwright
bioatla, inc.

Click the tags to see associated articles and topics

View Article Details
BioAtla, Inc. Announces Registered Direct Offering to Advance Two Mid-Stage Clinical ...

Added to Collection on: 2024-12-21 02:04:00

Tags for this article:

Immunology
Antibody-drug conjugate
Prospectus
Bi-specific T-cell engager
AXL receptor tyrosine kinase
Bispecific monoclonal antibody
Monoclonal antibody therapy
Seagen
bioatla, inc.

Click the tags to see associated articles and topics

View Article Details